Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FBPZF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,655
Award facts
- Contract value 100% obligated
- $10,655.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,655.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on December 15, 2025, with an ultimate completion date of January 7, 2026, carries no set-aside designation, indicating the award was made through open competition. DMS Pharmaceutical Group will perform under its existing Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for comprehensive pharmaceutical supply to Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group's selection reflects its established capability as a critical supplier within the federal pharmaceutical supply chain, with demonstrated performance delivering diverse products ranging from specialty biologics and oncology treatments to contraceptive devices and routine pharmaceuticals. The company's registration in the System for Award Management since 2001 and its substantial recent contracting activity with the Defense Logistics Agency Medical Supply Chain division underscore its competitive positioning. The PPV-G GEN V master contract, with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders such as this one to support recurring medical supply needs across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FBPZF?
SPE2DR26FBPZF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FBPZF worth?
The government has obligated $10,655 on SPE2DR26FBPZF.
Is contract SPE2DR26FBPZF an order under another contract?
Yes. SPE2DR26FBPZF is a delivery order under SPE2DR25D9304, an indefinite delivery contract.
Was contract SPE2DR26FBPZF competed?
The extent of competition for SPE2DR26FBPZF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award